SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-032294
Filing Date
2024-08-14
Accepted
2024-08-14 16:38:58
Documents
68
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 994767
2 ex3-1.htm EX-3.1 12470
3 ex31-1.htm EX-31.1 13796
4 ex31-2.htm EX-31.2 13883
5 ex32-1.htm EX-32.1 5660
6 ex32-2.htm EX-32.2 5428
  Complete submission text file 0001493152-24-032294.txt   5504437

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE tvgn-20240630.xsd EX-101.SCH 41996
8 XBRL CALCULATION FILE tvgn-20240630_cal.xml EX-101.CAL 57510
9 XBRL DEFINITION FILE tvgn-20240630_def.xml EX-101.DEF 252021
10 XBRL LABEL FILE tvgn-20240630_lab.xml EX-101.LAB 396386
11 XBRL PRESENTATION FILE tvgn-20240630_pre.xml EX-101.PRE 342669
70 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 703019
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

IRS No.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41002 | Film No.: 241208859
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)